Received by email:

File: '\\doc\emailin\20210122 153600 Attachment Havn NR - Jan 22 - Grant of Stock Options and RSRs - V4 (Cassels Edits
--->).docx'


  






Havn Life Grants Stock Options and Restricted Share Rights
January 22, 2021
Vancouver, BC - Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life") announces t
--->hat it has granted 250,000 incentive stock options (the "Options") at an exercise price of $0.85 per common share for 
--->a five year term. 
Further, the Company has granted 50,000 restricted share rights (the "RSRs") with a one-eight (1/8th) of the RSRs to v
--->est every three months beginning April 21, 2021. 
The Options and RSRs were granted to a director of the Company under the Company's Equity Incentive Plan.  
The Company also announces that it has issued an aggregate of 384,896 common shares (the "Common Shares") at a deemed 
--->price of $0.96 per Common Share in the capital of the Company to certain consultants of the Company for past services 
--->rendered to the Company. 
On Behalf of The Board of Directors
Tim Moore
Chief Executive Officer

About Havn Life Sciences Inc. 

Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research.
---> The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi
--->, and the development of natural health care products from non-regulated compounds. Learn more at: havnlife.com and fo
--->llow us on Facebook, Twitter, Instagram, and Youtube

Contact:

Investor Relations: ir@havnlife.com  604 687 7130
Media: savi@emergence-creative.com 647 896-8078


Cautionary Note Regarding Forward-Looking Statements 
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to 
--->statements regarding the Company's business, products and future of the Company's business. Although the Company belie
--->ves that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that 
--->such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking infor
--->mation. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performa
--->nce and developments to differ materially from those contemplated by these statements depending on, among other things
--->, the risks that the Company's products and plan will vary from those stated in this news release and the Company may 
--->not be able to carry out its business plans as expected. Except as required by law, the Company expressly disclaims an
--->y obligation and does not intend to update any forward-looking statements or forward-looking information in this news 
--->release. Although the Company believes that the expectations reflected in the forward-looking information are reasonab
--->le there can be no assurance that such expectations will prove to be correct. The statements in this news release are 
--->made as of the date of this release.
The CSE has not reviewed, approved or disapproved the content of this press release